Prescription with function for mitigating and curing osteoarthrosis

Abstract

The invention discloses a prescription with function for mitigating and curing osteoarthrosis, which comprises the components by weight percent: 3.3-66.7% of glucosamine hydrochloride, 10.67-16% of chondroitin sulfuric acid, 4-9.33% of soybean extract, 2.67-5.33% of pseudo-ginseng extract, 4-13.33% of drynaria rhizome extract, 1.33-4% of antioxygen, 1-3% of lubricating agent A and 0.267-0.533% of lubricating agent B. The preparation method of the prescription comprises the steps of: jointly mixing, filling capsule, polishing, detecting semi-manufactured goods and packing into capsule dosage. With the clinical observation of Shanghai No.6 People's Hospital, the prescription has high ramollescence for osteophyte or bony spur, has various coordinated effects of analgesia, anti-inflammation, detumescence and microcirculation improvement, and the like, and has effective rate of 86.67% for curing osteoarthrosis.

Description

technical field [0001] The invention relates to a capsule formula, in particular to a formula capable of alleviating and treating osteoarthritis. Background technique [0002] A symposium was held in Sweden in 1998. The meeting focused on osteoarthritis, low back pain, trauma, osteoporosis and diseases that lead to children's disabilities, and finally agreed to carry out "Bone and Joint 10 Years (2000-2010)" The bone and joint decade 2000-2010" (abbreviated as 10 years of bone and joint). The purpose is to remind people to pay attention to and prevent bone and joint diseases. Data from the World Health Organization (WHO) shows that with age, the population suffering from bone and joint diseases also increases proportionally, and female patients are higher than male patients, and over 75 years old, female patients are as high as nearly 100%. [0003] The first-generation product is a glucosamine capsule product with glucosamine as its raw material. This product can only pre...

AI Technical Summary

Problems solved by technology

[0004] With the aim of repairing cartilage, nourishing lubricant, and preventing osteoporosis, the second-generation product compound chondroitin capsules has been developed, and chondroitin sulfate and soybean isoflavones have been newly added. Together with the first-generation products, it has achieved great results after market application. The effect is good, but it also reflects some shortcomings. First, some patients reported that it could not alleviate the problem of joint pain. Second, the number of capsules taken every day increased, which was inconvenient for middle-aged and elderly patients to swallow. It brings about an increase in the consumption of capsule shells, and some middle-aged and elderly patients have poor gastrointestinal digestion, which brings the accumulation effect and feels stomach discomfort. Third, the monthly consumption increases, which brings economic burden